 | • レポートコード：GIR-22F19480 • 出版社/出版日：GlobalInfoResearch / 2022年11月 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「Global Oral Contraceptive Drugs Market 2022」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 グローバルインフォリサーチ社の最新の調査によると、世界の経口避妊薬の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 経口避妊薬市場はタイプ（種類）とアプリケーション（用途）によって区分されます。2017年～2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 タイプ別セグメントは次をカバーします。 ・長時間作用型避妊薬、短時間作用型避妊薬、緊急避妊薬 アプリケーション別セグメントは次のように区分されます。 ・病院、薬局、その他 世界の経口避妊薬市場の主要な市場プレーヤーは以下のとおりです。 ・Bayer、Pfizer、Teva Pharmaceutical、Merck、Actavis、Johnson & Johnson、Gedeon Richter、Novo Nordisk A/S、ZiZhu、Baijingyu、Huazhong 地域別セグメントは次の地域・国をカバーします。 ・北米市場（米国、カナダ、メキシコ） ・ヨーロッパ市場（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋市場（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南米市場（ブラジル、アルゼンチン、コロンビア） ・中東・アフリカ市場（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、経口避妊薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な経口避妊薬メーカーの企業概要、2019年～2022年までの経口避妊薬の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な経口避妊薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別経口避妊薬の販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までの経口避妊薬のタイプ別とアプリケーション別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での経口避妊薬市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、および経口避妊薬の産業チェーンを掲載しています。 ・第13、14、15章では、経口避妊薬の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 - 経口避妊薬の概要 - タイプ別分析（2017年vs2021年vs2028年）：長時間作用型避妊薬、短時間作用型避妊薬、緊急避妊薬 - アプリケーション別分析（2017年vs2021年vs2028年）：病院、薬局、その他 - 世界の経口避妊薬市場規模・予測 - 世界の経口避妊薬生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Bayer、Pfizer、Teva Pharmaceutical、Merck、Actavis、Johnson & Johnson、Gedeon Richter、Novo Nordisk A/S、ZiZhu、Baijingyu、Huazhong ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・タイプ別分析2017年-2028年：長時間作用型避妊薬、短時間作用型避妊薬、緊急避妊薬 ・アプリケーション別分析2017年-2028年：病院、薬局、その他 ・経口避妊薬の北米市場分析 - 経口避妊薬の北米市場：タイプ別市場規模2017年-2028年 - 経口避妊薬の北米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・経口避妊薬のヨーロッパ市場分析 - ：経口避妊薬のヨーロッパ市場：タイプ別市場規模2017年-2028年 - ：経口避妊薬のヨーロッパ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・経口避妊薬のアジア太平洋市場分析 - 経口避妊薬のアジア太平洋市場：タイプ別市場規模2017年-2028年 - 経口避妊薬のアジア太平洋市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・経口避妊薬の南米市場分析 - 経口避妊薬の南米市場：タイプ別市場規模2017年-2028年 - 経口避妊薬の南米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・経口避妊薬の中東・アフリカ市場分析 - 経口避妊薬の中東・アフリカ市場：タイプ別市場規模2017年-2028年 - 経口避妊薬の中東・アフリカ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Oral Contraceptive Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Oral Contraceptive Drugs market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Oral Contraceptive Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Long-acting Contraceptives segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Oral Contraceptive Drugs include Bayer, Pfizer, Teva Pharmaceutical, Merck, and Actavis, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Oral Contraceptive Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Long-acting Contraceptives
Short-acting Contraceptives
Emergency Contraceptives
Market segment by Application can be divided into
Hospital
Pharmacy
Other
The key market players for global Oral Contraceptive Drugs market are listed below:
Bayer
Pfizer
Teva Pharmaceutical
Merck
Actavis
Johnson & Johnson
Gedeon Richter
Novo Nordisk A/S
ZiZhu
Baijingyu
Huazhong
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Oral Contraceptive Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Oral Contraceptive Drugs, with price, sales, revenue and global market share of Oral Contraceptive Drugs from 2019 to 2022.
Chapter 3, the Oral Contraceptive Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oral Contraceptive Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Oral Contraceptive Drugs market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Oral Contraceptive Drugs.
Chapter 13, 14, and 15, to describe Oral Contraceptive Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Oral Contraceptive Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Oral Contraceptive Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Long-acting Contraceptives
1.2.3 Short-acting Contraceptives
1.2.4 Emergency Contraceptives
1.3 Market Analysis by Application
1.3.1 Overview: Global Oral Contraceptive Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Other
1.4 Global Oral Contraceptive Drugs Market Size & Forecast
1.4.1 Global Oral Contraceptive Drugs Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Oral Contraceptive Drugs Sales in Volume (2017-2028)
1.4.3 Global Oral Contraceptive Drugs Price (2017-2028)
1.5 Global Oral Contraceptive Drugs Production Capacity Analysis
1.5.1 Global Oral Contraceptive Drugs Total Production Capacity (2017-2028)
1.5.2 Global Oral Contraceptive Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Oral Contraceptive Drugs Market Drivers
1.6.2 Oral Contraceptive Drugs Market Restraints
1.6.3 Oral Contraceptive Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Bayer
2.1.1 Bayer Details
2.1.2 Bayer Major Business
2.1.3 Bayer Oral Contraceptive Drugs Product and Services
2.1.4 Bayer Oral Contraceptive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Oral Contraceptive Drugs Product and Services
2.2.4 Pfizer Oral Contraceptive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Teva Pharmaceutical
2.3.1 Teva Pharmaceutical Details
2.3.2 Teva Pharmaceutical Major Business
2.3.3 Teva Pharmaceutical Oral Contraceptive Drugs Product and Services
2.3.4 Teva Pharmaceutical Oral Contraceptive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business
2.4.3 Merck Oral Contraceptive Drugs Product and Services
2.4.4 Merck Oral Contraceptive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Actavis
2.5.1 Actavis Details
2.5.2 Actavis Major Business
2.5.3 Actavis Oral Contraceptive Drugs Product and Services
2.5.4 Actavis Oral Contraceptive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Johnson & Johnson
2.6.1 Johnson & Johnson Details
2.6.2 Johnson & Johnson Major Business
2.6.3 Johnson & Johnson Oral Contraceptive Drugs Product and Services
2.6.4 Johnson & Johnson Oral Contraceptive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Gedeon Richter
2.7.1 Gedeon Richter Details
2.7.2 Gedeon Richter Major Business
2.7.3 Gedeon Richter Oral Contraceptive Drugs Product and Services
2.7.4 Gedeon Richter Oral Contraceptive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Novo Nordisk A/S
2.8.1 Novo Nordisk A/S Details
2.8.2 Novo Nordisk A/S Major Business
2.8.3 Novo Nordisk A/S Oral Contraceptive Drugs Product and Services
2.8.4 Novo Nordisk A/S Oral Contraceptive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 ZiZhu
2.9.1 ZiZhu Details
2.9.2 ZiZhu Major Business
2.9.3 ZiZhu Oral Contraceptive Drugs Product and Services
2.9.4 ZiZhu Oral Contraceptive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Baijingyu
2.10.1 Baijingyu Details
2.10.2 Baijingyu Major Business
2.10.3 Baijingyu Oral Contraceptive Drugs Product and Services
2.10.4 Baijingyu Oral Contraceptive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Huazhong
2.11.1 Huazhong Details
2.11.2 Huazhong Major Business
2.11.3 Huazhong Oral Contraceptive Drugs Product and Services
2.11.4 Huazhong Oral Contraceptive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Oral Contraceptive Drugs Breakdown Data by Manufacturer
3.1 Global Oral Contraceptive Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Oral Contraceptive Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Oral Contraceptive Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Oral Contraceptive Drugs Manufacturer Market Share in 2021
3.4.2 Top 6 Oral Contraceptive Drugs Manufacturer Market Share in 2021
3.5 Global Oral Contraceptive Drugs Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Oral Contraceptive Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Oral Contraceptive Drugs Market Size by Region
4.1.1 Global Oral Contraceptive Drugs Sales in Volume by Region (2017-2028)
4.1.2 Global Oral Contraceptive Drugs Revenue by Region (2017-2028)
4.2 North America Oral Contraceptive Drugs Revenue (2017-2028)
4.3 Europe Oral Contraceptive Drugs Revenue (2017-2028)
4.4 Asia-Pacific Oral Contraceptive Drugs Revenue (2017-2028)
4.5 South America Oral Contraceptive Drugs Revenue (2017-2028)
4.6 Middle East and Africa Oral Contraceptive Drugs Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Oral Contraceptive Drugs Sales in Volume by Type (2017-2028)
5.2 Global Oral Contraceptive Drugs Revenue by Type (2017-2028)
5.3 Global Oral Contraceptive Drugs Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Oral Contraceptive Drugs Sales in Volume by Application (2017-2028)
6.2 Global Oral Contraceptive Drugs Revenue by Application (2017-2028)
6.3 Global Oral Contraceptive Drugs Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Oral Contraceptive Drugs Sales by Type (2017-2028)
7.2 North America Oral Contraceptive Drugs Sales by Application (2017-2028)
7.3 North America Oral Contraceptive Drugs Market Size by Country
7.3.1 North America Oral Contraceptive Drugs Sales in Volume by Country (2017-2028)
7.3.2 North America Oral Contraceptive Drugs Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Oral Contraceptive Drugs Sales by Type (2017-2028)
8.2 Europe Oral Contraceptive Drugs Sales by Application (2017-2028)
8.3 Europe Oral Contraceptive Drugs Market Size by Country
8.3.1 Europe Oral Contraceptive Drugs Sales in Volume by Country (2017-2028)
8.3.2 Europe Oral Contraceptive Drugs Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Oral Contraceptive Drugs Sales by Type (2017-2028)
9.2 Asia-Pacific Oral Contraceptive Drugs Sales by Application (2017-2028)
9.3 Asia-Pacific Oral Contraceptive Drugs Market Size by Region
9.3.1 Asia-Pacific Oral Contraceptive Drugs Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Oral Contraceptive Drugs Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Oral Contraceptive Drugs Sales by Type (2017-2028)
10.2 South America Oral Contraceptive Drugs Sales by Application (2017-2028)
10.3 South America Oral Contraceptive Drugs Market Size by Country
10.3.1 South America Oral Contraceptive Drugs Sales in Volume by Country (2017-2028)
10.3.2 South America Oral Contraceptive Drugs Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Oral Contraceptive Drugs Sales by Type (2017-2028)
11.2 Middle East & Africa Oral Contraceptive Drugs Sales by Application (2017-2028)
11.3 Middle East & Africa Oral Contraceptive Drugs Market Size by Country
11.3.1 Middle East & Africa Oral Contraceptive Drugs Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Oral Contraceptive Drugs Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Oral Contraceptive Drugs and Key Manufacturers
12.2 Manufacturing Costs Percentage of Oral Contraceptive Drugs
12.3 Oral Contraceptive Drugs Production Process
12.4 Oral Contraceptive Drugs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Oral Contraceptive Drugs Typical Distributors
13.3 Oral Contraceptive Drugs Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer